nodes	percent_of_prediction	percent_of_DWPC	metapath
Lapatinib—CYP2C8—Levothyroxine—hypothyroidism	0.136	0.227	CbGbCtD
Lapatinib—CYP2C8—Liotrix—hypothyroidism	0.132	0.222	CbGbCtD
Lapatinib—ABCB1—Liothyronine—hypothyroidism	0.0918	0.154	CbGbCtD
Lapatinib—ABCB1—Levothyroxine—hypothyroidism	0.0918	0.154	CbGbCtD
Lapatinib—ABCB1—Liotrix—hypothyroidism	0.0896	0.15	CbGbCtD
Lapatinib—CYP3A4—Levothyroxine—hypothyroidism	0.055	0.0923	CbGbCtD
Lapatinib—PI4KB—Synthesis of PIPs at the Golgi membrane—PIK3C2A—hypothyroidism	0.0109	0.0994	CbGpPWpGaD
Lapatinib—ERBB4—EV release from cardiac cells and their functional effects—PRL—hypothyroidism	0.00717	0.0652	CbGpPWpGaD
Lapatinib—PIK3C2B—Synthesis of PIPs at the plasma membrane—PIK3C2A—hypothyroidism	0.00697	0.0634	CbGpPWpGaD
Lapatinib—TAP1—adrenal cortex—hypothyroidism	0.00571	0.0287	CbGeAlD
Lapatinib—TAP1—heart—hypothyroidism	0.00552	0.0278	CbGeAlD
Lapatinib—PIK3C2B—adrenal cortex—hypothyroidism	0.00536	0.027	CbGeAlD
Lapatinib—PIK3C2B—heart—hypothyroidism	0.00519	0.0261	CbGeAlD
Lapatinib—PIK3C2B—Signaling events mediated by Stem cell factor receptor (c-Kit)—SH2B3—hypothyroidism	0.00492	0.0448	CbGpPWpGaD
Lapatinib—PIK3C2B—PI Metabolism—PIK3C2A—hypothyroidism	0.00492	0.0448	CbGpPWpGaD
Lapatinib—CYP2C19—urine—hypothyroidism	0.0049	0.0246	CbGeAlD
Lapatinib—PI4KB—PI Metabolism—PIK3C2A—hypothyroidism	0.00475	0.0432	CbGpPWpGaD
Lapatinib—TAP1—pituitary gland—hypothyroidism	0.00462	0.0232	CbGeAlD
Lapatinib—PIK3C2B—pituitary gland—hypothyroidism	0.00433	0.0218	CbGeAlD
Lapatinib—TAP1—adrenal gland—hypothyroidism	0.00412	0.0207	CbGeAlD
Lapatinib—TAP1—blood—hypothyroidism	0.00412	0.0207	CbGeAlD
Lapatinib—ERBB2—heart—hypothyroidism	0.00403	0.0203	CbGeAlD
Lapatinib—ERBB4—heart—hypothyroidism	0.00403	0.0203	CbGeAlD
Lapatinib—PI4KB—Integrins in angiogenesis—PIK3C2A—hypothyroidism	0.00401	0.0365	CbGpPWpGaD
Lapatinib—TAP1—thyroid gland—hypothyroidism	0.00398	0.02	CbGeAlD
Lapatinib—PI4KB—adrenal cortex—hypothyroidism	0.00391	0.0196	CbGeAlD
Lapatinib—PIK3C2B—adrenal gland—hypothyroidism	0.00387	0.0195	CbGeAlD
Lapatinib—PIK3C2B—blood—hypothyroidism	0.00387	0.0195	CbGeAlD
Lapatinib—TAP1—female gonad—hypothyroidism	0.00384	0.0193	CbGeAlD
Lapatinib—ERBB4—cardiovascular system—hypothyroidism	0.00381	0.0191	CbGeAlD
Lapatinib—ERBB2—cardiovascular system—hypothyroidism	0.00381	0.0191	CbGeAlD
Lapatinib—PI4KB—heart—hypothyroidism	0.00378	0.019	CbGeAlD
Lapatinib—PIK3C2B—thyroid gland—hypothyroidism	0.00374	0.0188	CbGeAlD
Lapatinib—Cardiac failure—Dextrothyroxine—hypothyroidism	0.00365	0.0385	CcSEcCtD
Lapatinib—Cardiac failure—Levothyroxine—hypothyroidism	0.00365	0.0385	CcSEcCtD
Lapatinib—PIK3C2B—female gonad—hypothyroidism	0.00361	0.0181	CbGeAlD
Lapatinib—ERBB2—gonad—hypothyroidism	0.00345	0.0174	CbGeAlD
Lapatinib—EGFR—heart—hypothyroidism	0.00342	0.0172	CbGeAlD
Lapatinib—TAP1—testis—hypothyroidism	0.00341	0.0171	CbGeAlD
Lapatinib—ERBB4—pituitary gland—hypothyroidism	0.00337	0.0169	CbGeAlD
Lapatinib—PIK3C2B—Signaling Pathways in Glioblastoma—PIK3C2A—hypothyroidism	0.00336	0.0306	CbGpPWpGaD
Lapatinib—Dehydration—Dextrothyroxine—hypothyroidism	0.00331	0.0349	CcSEcCtD
Lapatinib—Dehydration—Levothyroxine—hypothyroidism	0.00331	0.0349	CcSEcCtD
Lapatinib—PI4KB—gonad—hypothyroidism	0.00324	0.0163	CbGeAlD
Lapatinib—TAP1—liver—hypothyroidism	0.00322	0.0162	CbGeAlD
Lapatinib—PIK3C2B—testis—hypothyroidism	0.0032	0.0161	CbGeAlD
Lapatinib—PI4KB—pituitary gland—hypothyroidism	0.00316	0.0159	CbGeAlD
Lapatinib—TAP1—cerebellum—hypothyroidism	0.00315	0.0158	CbGeAlD
Lapatinib—PIK3C2B—liver—hypothyroidism	0.00303	0.0152	CbGeAlD
Lapatinib—ERBB2—adrenal gland—hypothyroidism	0.00301	0.0151	CbGeAlD
Lapatinib—ERBB2—blood—hypothyroidism	0.00301	0.0151	CbGeAlD
Lapatinib—PIK3C2B—cerebellum—hypothyroidism	0.00296	0.0149	CbGeAlD
Lapatinib—ERBB2—thyroid gland—hypothyroidism	0.0029	0.0146	CbGeAlD
Lapatinib—ERBB4—thyroid gland—hypothyroidism	0.0029	0.0146	CbGeAlD
Lapatinib—CYP3A4—urine—hypothyroidism	0.0029	0.0146	CbGeAlD
Lapatinib—Renal failure acute—Liotrix—hypothyroidism	0.00284	0.0299	CcSEcCtD
Lapatinib—PI4KB—adrenal gland—hypothyroidism	0.00282	0.0142	CbGeAlD
Lapatinib—PI4KB—blood—hypothyroidism	0.00282	0.0142	CbGeAlD
Lapatinib—ERBB2—female gonad—hypothyroidism	0.00281	0.0141	CbGeAlD
Lapatinib—PI4KB—Integrins in angiogenesis—VAV3—hypothyroidism	0.00275	0.0251	CbGpPWpGaD
Lapatinib—PI4KB—thyroid gland—hypothyroidism	0.00272	0.0137	CbGeAlD
Lapatinib—Cardiac failure—Liotrix—hypothyroidism	0.00269	0.0283	CcSEcCtD
Lapatinib—PIK3C2B—DNA Damage Response (only ATM dependent)—PIK3C2A—hypothyroidism	0.00268	0.0244	CbGpPWpGaD
Lapatinib—PI4KB—female gonad—hypothyroidism	0.00263	0.0132	CbGeAlD
Lapatinib—EGFR—adrenal gland—hypothyroidism	0.00255	0.0128	CbGeAlD
Lapatinib—ERBB2—testis—hypothyroidism	0.00249	0.0125	CbGeAlD
Lapatinib—ERBB4—testis—hypothyroidism	0.00249	0.0125	CbGeAlD
Lapatinib—EGFR—thyroid gland—hypothyroidism	0.00246	0.0124	CbGeAlD
Lapatinib—Dehydration—Liotrix—hypothyroidism	0.00244	0.0257	CcSEcCtD
Lapatinib—EGFR—female gonad—hypothyroidism	0.00238	0.012	CbGeAlD
Lapatinib—ERBB2—liver—hypothyroidism	0.00235	0.0118	CbGeAlD
Lapatinib—PI4KB—testis—hypothyroidism	0.00233	0.0117	CbGeAlD
Lapatinib—ERBB4—cerebellum—hypothyroidism	0.0023	0.0116	CbGeAlD
Lapatinib—ERBB2—cerebellum—hypothyroidism	0.0023	0.0116	CbGeAlD
Lapatinib—PIK3C2B—Phospholipid metabolism—PIK3C2A—hypothyroidism	0.00222	0.0202	CbGpPWpGaD
Lapatinib—PI4KB—liver—hypothyroidism	0.0022	0.0111	CbGeAlD
Lapatinib—Alopecia—Dextrothyroxine—hypothyroidism	0.00218	0.023	CcSEcCtD
Lapatinib—Alopecia—Levothyroxine—hypothyroidism	0.00218	0.023	CcSEcCtD
Lapatinib—PI4KB—cerebellum—hypothyroidism	0.00215	0.0108	CbGeAlD
Lapatinib—PI4KB—Phospholipid metabolism—PIK3C2A—hypothyroidism	0.00214	0.0195	CbGpPWpGaD
Lapatinib—EGFR—testis—hypothyroidism	0.00211	0.0106	CbGeAlD
Lapatinib—PIK3C2B—Regulation of Actin Cytoskeleton—PIK3C2A—hypothyroidism	0.00209	0.019	CbGpPWpGaD
Lapatinib—ERBB2—ErbB4 signaling events—PRL—hypothyroidism	0.00201	0.0183	CbGpPWpGaD
Lapatinib—EGFR—liver—hypothyroidism	0.002	0.01	CbGeAlD
Lapatinib—ERBB4—ErbB4 signaling events—PRL—hypothyroidism	0.00198	0.018	CbGpPWpGaD
Lapatinib—EGFR—cerebellum—hypothyroidism	0.00195	0.0098	CbGeAlD
Lapatinib—Palpitations—Levothyroxine—hypothyroidism	0.0019	0.02	CcSEcCtD
Lapatinib—Palpitations—Dextrothyroxine—hypothyroidism	0.0019	0.02	CcSEcCtD
Lapatinib—Arthralgia—Levothyroxine—hypothyroidism	0.00183	0.0193	CcSEcCtD
Lapatinib—Arthralgia—Dextrothyroxine—hypothyroidism	0.00183	0.0193	CcSEcCtD
Lapatinib—ERBB4—Nuclear signaling by ERBB4—PRL—hypothyroidism	0.00181	0.0165	CbGpPWpGaD
Lapatinib—PI4KB—Integrins in angiogenesis—IGF1—hypothyroidism	0.0017	0.0154	CbGpPWpGaD
Lapatinib—Alopecia—Liotrix—hypothyroidism	0.0016	0.0169	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.0016	0.0168	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.0016	0.0168	CcSEcCtD
Lapatinib—Insomnia—Levothyroxine—hypothyroidism	0.00158	0.0167	CcSEcCtD
Lapatinib—Insomnia—Dextrothyroxine—hypothyroidism	0.00158	0.0167	CcSEcCtD
Lapatinib—Dyspnoea—Levothyroxine—hypothyroidism	0.00156	0.0165	CcSEcCtD
Lapatinib—Dyspnoea—Dextrothyroxine—hypothyroidism	0.00156	0.0165	CcSEcCtD
Lapatinib—Fatigue—Dextrothyroxine—hypothyroidism	0.00151	0.0159	CcSEcCtD
Lapatinib—Fatigue—Levothyroxine—hypothyroidism	0.00151	0.0159	CcSEcCtD
Lapatinib—EGFR—Arf6 signaling events—TSHR—hypothyroidism	0.00147	0.0134	CbGpPWpGaD
Lapatinib—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.00143	0.0151	CcSEcCtD
Lapatinib—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.00143	0.0151	CcSEcCtD
Lapatinib—Palpitations—Liotrix—hypothyroidism	0.0014	0.0147	CcSEcCtD
Lapatinib—Abdominal pain—Dextrothyroxine—hypothyroidism	0.00138	0.0146	CcSEcCtD
Lapatinib—Abdominal pain—Levothyroxine—hypothyroidism	0.00138	0.0146	CcSEcCtD
Lapatinib—ERBB2—Signaling Pathways in Glioblastoma—PIK3C2A—hypothyroidism	0.00137	0.0125	CbGpPWpGaD
Lapatinib—Arthralgia—Liotrix—hypothyroidism	0.00134	0.0142	CcSEcCtD
Lapatinib—PIK3C2B—EGF/EGFR Signaling Pathway—VAV3—hypothyroidism	0.00134	0.0122	CbGpPWpGaD
Lapatinib—Anaphylactic shock—Liotrix—hypothyroidism	0.00129	0.0136	CcSEcCtD
Lapatinib—Infection—Liotrix—hypothyroidism	0.00128	0.0135	CcSEcCtD
Lapatinib—Asthenia—Levothyroxine—hypothyroidism	0.00126	0.0132	CcSEcCtD
Lapatinib—Asthenia—Dextrothyroxine—hypothyroidism	0.00126	0.0132	CcSEcCtD
Lapatinib—Pruritus—Dextrothyroxine—hypothyroidism	0.00124	0.0131	CcSEcCtD
Lapatinib—Pruritus—Levothyroxine—hypothyroidism	0.00124	0.0131	CcSEcCtD
Lapatinib—Anorexia—Liotrix—hypothyroidism	0.00123	0.0129	CcSEcCtD
Lapatinib—Diarrhoea—Levothyroxine—hypothyroidism	0.0012	0.0126	CcSEcCtD
Lapatinib—Diarrhoea—Dextrothyroxine—hypothyroidism	0.0012	0.0126	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.00117	0.0124	CcSEcCtD
Lapatinib—Insomnia—Liotrix—hypothyroidism	0.00117	0.0123	CcSEcCtD
Lapatinib—Dyspnoea—Liotrix—hypothyroidism	0.00115	0.0121	CcSEcCtD
Lapatinib—Decreased appetite—Liotrix—hypothyroidism	0.00112	0.0118	CcSEcCtD
Lapatinib—Vomiting—Levothyroxine—hypothyroidism	0.00111	0.0117	CcSEcCtD
Lapatinib—Vomiting—Dextrothyroxine—hypothyroidism	0.00111	0.0117	CcSEcCtD
Lapatinib—Fatigue—Liotrix—hypothyroidism	0.00111	0.0117	CcSEcCtD
Lapatinib—Rash—Dextrothyroxine—hypothyroidism	0.0011	0.0116	CcSEcCtD
Lapatinib—Rash—Levothyroxine—hypothyroidism	0.0011	0.0116	CcSEcCtD
Lapatinib—Dermatitis—Levothyroxine—hypothyroidism	0.0011	0.0116	CcSEcCtD
Lapatinib—Dermatitis—Dextrothyroxine—hypothyroidism	0.0011	0.0116	CcSEcCtD
Lapatinib—Constipation—Liotrix—hypothyroidism	0.0011	0.0116	CcSEcCtD
Lapatinib—Headache—Dextrothyroxine—hypothyroidism	0.0011	0.0116	CcSEcCtD
Lapatinib—Headache—Levothyroxine—hypothyroidism	0.0011	0.0116	CcSEcCtD
Lapatinib—ERBB2—DNA Damage Response (only ATM dependent)—PIK3C2A—hypothyroidism	0.00109	0.00992	CbGpPWpGaD
Lapatinib—TAP1—Adaptive Immune System—CLTC—hypothyroidism	0.00107	0.00974	CbGpPWpGaD
Lapatinib—Gastrointestinal pain—Liotrix—hypothyroidism	0.00105	0.0111	CcSEcCtD
Lapatinib—Nausea—Levothyroxine—hypothyroidism	0.00104	0.011	CcSEcCtD
Lapatinib—Nausea—Dextrothyroxine—hypothyroidism	0.00104	0.011	CcSEcCtD
Lapatinib—Abdominal pain—Liotrix—hypothyroidism	0.00102	0.0107	CcSEcCtD
Lapatinib—PIK3C2B—Metabolism—IYD—hypothyroidism	0.000964	0.00877	CbGpPWpGaD
Lapatinib—Hypersensitivity—Liotrix—hypothyroidism	0.000949	0.01	CcSEcCtD
Lapatinib—CYP2C19—blood—hypothyroidism	0.000937	0.00471	CbGeAlD
Lapatinib—PI4KB—Metabolism—IYD—hypothyroidism	0.000931	0.00847	CbGpPWpGaD
Lapatinib—Asthenia—Liotrix—hypothyroidism	0.000924	0.00974	CcSEcCtD
Lapatinib—CYP2C8—pituitary gland—hypothyroidism	0.000916	0.0046	CbGeAlD
Lapatinib—Pruritus—Liotrix—hypothyroidism	0.000912	0.00961	CcSEcCtD
Lapatinib—ERBB2—Signaling by SCF-KIT—SH2B3—hypothyroidism	0.000887	0.00808	CbGpPWpGaD
Lapatinib—Diarrhoea—Liotrix—hypothyroidism	0.000882	0.00929	CcSEcCtD
Lapatinib—ERBB4—Signaling by SCF-KIT—SH2B3—hypothyroidism	0.000874	0.00796	CbGpPWpGaD
Lapatinib—EGFR—Syndecan-3-mediated signaling events—POMC—hypothyroidism	0.000865	0.00787	CbGpPWpGaD
Lapatinib—PIK3C2B—Metabolism—ATP5O—hypothyroidism	0.00082	0.00746	CbGpPWpGaD
Lapatinib—Vomiting—Liotrix—hypothyroidism	0.000819	0.00864	CcSEcCtD
Lapatinib—CYP2C8—blood—hypothyroidism	0.000818	0.00411	CbGeAlD
Lapatinib—Rash—Liotrix—hypothyroidism	0.000812	0.00856	CcSEcCtD
Lapatinib—Dermatitis—Liotrix—hypothyroidism	0.000812	0.00856	CcSEcCtD
Lapatinib—Headache—Liotrix—hypothyroidism	0.000807	0.00851	CcSEcCtD
Lapatinib—PI4KB—Metabolism—ATP5O—hypothyroidism	0.000792	0.0072	CbGpPWpGaD
Lapatinib—PIK3C2B—Metabolism—TPO—hypothyroidism	0.000771	0.00701	CbGpPWpGaD
Lapatinib—Nausea—Liotrix—hypothyroidism	0.000765	0.00807	CcSEcCtD
Lapatinib—PI4KB—Metabolism—TPO—hypothyroidism	0.000744	0.00677	CbGpPWpGaD
Lapatinib—CYP3A5—blood—hypothyroidism	0.000738	0.00371	CbGeAlD
Lapatinib—CYP2C19—liver—hypothyroidism	0.000733	0.00368	CbGeAlD
Lapatinib—PIK3C2B—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000714	0.0065	CbGpPWpGaD
Lapatinib—EGFR—Signaling events mediated by PTP1B—PRL—hypothyroidism	0.000707	0.00643	CbGpPWpGaD
Lapatinib—PI4KB—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.00069	0.00628	CbGpPWpGaD
Lapatinib—CYP3A5—female gonad—hypothyroidism	0.000688	0.00346	CbGeAlD
Lapatinib—CYP2C8—testis—hypothyroidism	0.000677	0.0034	CbGeAlD
Lapatinib—ERBB2—Axon guidance—CLTC—hypothyroidism	0.000664	0.00605	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways in Glioblastoma—PIK3C2A—hypothyroidism	0.000662	0.00602	CbGpPWpGaD
Lapatinib—TAP1—Immune System—CLTC—hypothyroidism	0.000649	0.00591	CbGpPWpGaD
Lapatinib—CYP2C8—liver—hypothyroidism	0.00064	0.00321	CbGeAlD
Lapatinib—ERBB2—Signaling by ERBB4—PRL—hypothyroidism	0.00062	0.00564	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by ERBB4—PRL—hypothyroidism	0.000611	0.00556	CbGpPWpGaD
Lapatinib—CYP3A5—liver—hypothyroidism	0.000577	0.0029	CbGeAlD
Lapatinib—CYP3A4—blood—hypothyroidism	0.000554	0.00278	CbGeAlD
Lapatinib—ERBB2—EGF/EGFR Signaling Pathway—VAV3—hypothyroidism	0.000545	0.00496	CbGpPWpGaD
Lapatinib—ABCB1—adrenal cortex—hypothyroidism	0.000543	0.00273	CbGeAlD
Lapatinib—ERBB2—DAP12 signaling—VAV3—hypothyroidism	0.00054	0.00491	CbGpPWpGaD
Lapatinib—ERBB4—DAP12 signaling—VAV3—hypothyroidism	0.000532	0.00484	CbGpPWpGaD
Lapatinib—ABCB1—heart—hypothyroidism	0.000525	0.00264	CbGeAlD
Lapatinib—ERBB2—DAP12 interactions—VAV3—hypothyroidism	0.000508	0.00462	CbGpPWpGaD
Lapatinib—ERBB2—Fc epsilon receptor (FCERI) signaling—VAV3—hypothyroidism	0.000508	0.00462	CbGpPWpGaD
Lapatinib—ERBB4—DAP12 interactions—VAV3—hypothyroidism	0.0005	0.00455	CbGpPWpGaD
Lapatinib—ERBB4—Fc epsilon receptor (FCERI) signaling—VAV3—hypothyroidism	0.0005	0.00455	CbGpPWpGaD
Lapatinib—ABCB1—cardiovascular system—hypothyroidism	0.000496	0.00249	CbGeAlD
Lapatinib—EGFR—Stabilization and expansion of the E-cadherin adherens junction—IGF1—hypothyroidism	0.000478	0.00435	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—CLTC—hypothyroidism	0.000474	0.00431	CbGpPWpGaD
Lapatinib—ABCB1—gonad—hypothyroidism	0.00045	0.00226	CbGeAlD
Lapatinib—ABCB1—pituitary gland—hypothyroidism	0.000439	0.00221	CbGeAlD
Lapatinib—CYP3A4—liver—hypothyroidism	0.000433	0.00218	CbGeAlD
Lapatinib—EGFR—Signaling by SCF-KIT—SH2B3—hypothyroidism	0.000429	0.00391	CbGpPWpGaD
Lapatinib—EGFR—Regulation of Actin Cytoskeleton—PIK3C2A—hypothyroidism	0.000411	0.00374	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—CLTC—hypothyroidism	0.000402	0.00366	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—CLTC—hypothyroidism	0.000396	0.0036	CbGpPWpGaD
Lapatinib—ABCB1—adrenal gland—hypothyroidism	0.000392	0.00197	CbGeAlD
Lapatinib—ABCB1—blood—hypothyroidism	0.000392	0.00197	CbGeAlD
Lapatinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—hypothyroidism	0.000385	0.00351	CbGpPWpGaD
Lapatinib—ABCB1—thyroid gland—hypothyroidism	0.000378	0.0019	CbGeAlD
Lapatinib—EGFR—SHP2 signaling—IGF1—hypothyroidism	0.000369	0.00336	CbGpPWpGaD
Lapatinib—ABCB1—female gonad—hypothyroidism	0.000366	0.00184	CbGeAlD
Lapatinib—PIK3C2B—Metabolism—TSHB—hypothyroidism	0.000357	0.00325	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by NGF—VAV3—hypothyroidism	0.000346	0.00315	CbGpPWpGaD
Lapatinib—PI4KB—Metabolism—TSHB—hypothyroidism	0.000345	0.00314	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by NGF—VAV3—hypothyroidism	0.000341	0.0031	CbGpPWpGaD
Lapatinib—TAP1—Immune System—PRL—hypothyroidism	0.000331	0.00301	CbGpPWpGaD
Lapatinib—ABCB1—testis—hypothyroidism	0.000324	0.00163	CbGeAlD
Lapatinib—EGFR—Axon guidance—CLTC—hypothyroidism	0.000321	0.00292	CbGpPWpGaD
Lapatinib—PIK3C2B—Metabolism—PIK3C2A—hypothyroidism	0.000318	0.00289	CbGpPWpGaD
Lapatinib—PIK3C2B—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	0.000314	0.00286	CbGpPWpGaD
Lapatinib—ERBB2—Axon guidance—VAV3—hypothyroidism	0.000313	0.00285	CbGpPWpGaD
Lapatinib—PI4KB—Metabolism—PIK3C2A—hypothyroidism	0.000307	0.0028	CbGpPWpGaD
Lapatinib—ABCB1—liver—hypothyroidism	0.000307	0.00154	CbGeAlD
Lapatinib—TAP1—Immune System—VAV3—hypothyroidism	0.000306	0.00278	CbGpPWpGaD
Lapatinib—PI4KB—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	0.000303	0.00276	CbGpPWpGaD
Lapatinib—EGFR—Signaling by ERBB4—PRL—hypothyroidism	0.0003	0.00273	CbGpPWpGaD
Lapatinib—ABCB1—cerebellum—hypothyroidism	0.0003	0.00151	CbGeAlD
Lapatinib—ERBB2—Focal Adhesion—IGF1—hypothyroidism	0.000295	0.00269	CbGpPWpGaD
Lapatinib—ERBB2—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	0.000294	0.00268	CbGpPWpGaD
Lapatinib—PIK3C2B—Metabolism—SLC5A5—hypothyroidism	0.000267	0.00243	CbGpPWpGaD
Lapatinib—EGFR—EGF/EGFR Signaling Pathway—VAV3—hypothyroidism	0.000264	0.0024	CbGpPWpGaD
Lapatinib—EGFR—DAP12 signaling—VAV3—hypothyroidism	0.000261	0.00237	CbGpPWpGaD
Lapatinib—PI4KB—Metabolism—SLC5A5—hypothyroidism	0.000258	0.00235	CbGpPWpGaD
Lapatinib—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.00025	0.00227	CbGpPWpGaD
Lapatinib—EGFR—DAP12 interactions—VAV3—hypothyroidism	0.000245	0.00223	CbGpPWpGaD
Lapatinib—EGFR—Fc epsilon receptor (FCERI) signaling—VAV3—hypothyroidism	0.000245	0.00223	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—CLTC—hypothyroidism	0.000244	0.00222	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—CLTC—hypothyroidism	0.00024	0.00219	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—CLTC—hypothyroidism	0.000229	0.00209	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—VAV3—hypothyroidism	0.000223	0.00203	CbGpPWpGaD
Lapatinib—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000216	0.00197	CbGpPWpGaD
Lapatinib—CYP3A5—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000203	0.00184	CbGpPWpGaD
Lapatinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—hypothyroidism	0.000202	0.00184	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—VAV3—hypothyroidism	0.000197	0.0018	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—CLTC—hypothyroidism	0.000194	0.00177	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—VAV3—hypothyroidism	0.000194	0.00177	CbGpPWpGaD
Lapatinib—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000193	0.00176	CbGpPWpGaD
Lapatinib—CYP2C8—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000175	0.0016	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—VAV3—hypothyroidism	0.000167	0.00152	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—CLTC—hypothyroidism	0.000158	0.00144	CbGpPWpGaD
Lapatinib—CYP2C19—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000157	0.00142	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—CLTC—hypothyroidism	0.000155	0.00141	CbGpPWpGaD
Lapatinib—EGFR—Axon guidance—VAV3—hypothyroidism	0.000151	0.00138	CbGpPWpGaD
Lapatinib—EGFR—Focal Adhesion—IGF1—hypothyroidism	0.000143	0.0013	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	0.000142	0.00129	CbGpPWpGaD
Lapatinib—ABCB1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000142	0.00129	CbGpPWpGaD
Lapatinib—PIK3C2B—Metabolism—POMC—hypothyroidism	0.00014	0.00127	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—TRH—hypothyroidism	0.000136	0.00124	CbGpPWpGaD
Lapatinib—PI4KB—Metabolism—POMC—hypothyroidism	0.000135	0.00123	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—TRH—hypothyroidism	0.000134	0.00122	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—IYD—hypothyroidism	0.000127	0.00116	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—PRL—hypothyroidism	0.000124	0.00113	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—PRL—hypothyroidism	0.000122	0.00111	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—TSHB—hypothyroidism	0.000121	0.00111	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—TSHR—hypothyroidism	0.000121	0.00111	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—TSHB—hypothyroidism	0.00012	0.00109	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—TSHR—hypothyroidism	0.00012	0.00109	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CLTC—hypothyroidism	0.000118	0.00107	CbGpPWpGaD
Lapatinib—ABCB1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000117	0.00107	CbGpPWpGaD
Lapatinib—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000116	0.00106	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—VAV3—hypothyroidism	0.000115	0.00105	CbGpPWpGaD
Lapatinib—ERBB2—Disease—PRL—hypothyroidism	0.000115	0.00104	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—VAV3—hypothyroidism	0.000113	0.00103	CbGpPWpGaD
Lapatinib—ERBB4—Disease—PRL—hypothyroidism	0.000113	0.00103	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—TRH—hypothyroidism	0.000112	0.00101	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—IYD—hypothyroidism	0.00011	0.001	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—SH2B3—hypothyroidism	0.000108	0.000985	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—VAV3—hypothyroidism	0.000108	0.000983	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—ATP5O—hypothyroidism	0.000108	0.000982	CbGpPWpGaD
Lapatinib—CYP3A5—Biological oxidations—POMC—hypothyroidism	0.000108	0.000979	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—SH2B3—hypothyroidism	0.000107	0.000971	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—TPO—hypothyroidism	0.000101	0.000923	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—TSHB—hypothyroidism	9.94e-05	0.000905	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—TSHR—hypothyroidism	9.94e-05	0.000905	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—IYD—hypothyroidism	9.81e-05	0.000893	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—IYD—hypothyroidism	9.58e-05	0.000872	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—VAV3—hypothyroidism	9.54e-05	0.000868	CbGpPWpGaD
Lapatinib—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	9.41e-05	0.000857	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—ATP5O—hypothyroidism	9.35e-05	0.000851	CbGpPWpGaD
Lapatinib—CYP2C8—Biological oxidations—POMC—hypothyroidism	9.32e-05	0.000848	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—TPO—hypothyroidism	8.79e-05	0.0008	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—ATP5O—hypothyroidism	8.34e-05	0.000759	CbGpPWpGaD
Lapatinib—CYP2C19—Biological oxidations—POMC—hypothyroidism	8.32e-05	0.000757	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—ATP5O—hypothyroidism	8.14e-05	0.000741	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	8.14e-05	0.000741	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—PRL—hypothyroidism	8.03e-05	0.000731	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—PRL—hypothyroidism	7.91e-05	0.00072	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—TPO—hypothyroidism	7.84e-05	0.000714	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—TPO—hypothyroidism	7.66e-05	0.000697	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CLTC—hypothyroidism	7.62e-05	0.000694	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—VAV3—hypothyroidism	7.43e-05	0.000676	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—VAV3—hypothyroidism	7.32e-05	0.000666	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	7.27e-05	0.000661	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	7.18e-05	0.000654	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—AVP—hypothyroidism	7.16e-05	0.000652	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—AVP—hypothyroidism	7.05e-05	0.000642	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—TRH—hypothyroidism	6.59e-05	0.0006	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—VAV3—hypothyroidism	6.08e-05	0.000553	CbGpPWpGaD
Lapatinib—EGFR—Immune System—PRL—hypothyroidism	6.01e-05	0.000547	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—IYD—hypothyroidism	5.9e-05	0.000537	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—TSHB—hypothyroidism	5.87e-05	0.000534	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—TSHR—hypothyroidism	5.87e-05	0.000534	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—AVP—hypothyroidism	5.86e-05	0.000533	CbGpPWpGaD
Lapatinib—ABCB1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	5.66e-05	0.000516	CbGpPWpGaD
Lapatinib—EGFR—Immune System—VAV3—hypothyroidism	5.56e-05	0.000506	CbGpPWpGaD
Lapatinib—EGFR—Disease—PRL—hypothyroidism	5.54e-05	0.000505	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—SH2B3—hypothyroidism	5.23e-05	0.000476	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—ATP5O—hypothyroidism	5.02e-05	0.000457	CbGpPWpGaD
Lapatinib—CYP3A4—Biological oxidations—POMC—hypothyroidism	5e-05	0.000455	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—POMC—hypothyroidism	4.76e-05	0.000433	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—TPO—hypothyroidism	4.72e-05	0.000429	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—TSHB—hypothyroidism	4.7e-05	0.000428	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—POMC—hypothyroidism	4.69e-05	0.000426	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—IGF1—hypothyroidism	4.58e-05	0.000416	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—IGF1—hypothyroidism	4.51e-05	0.00041	CbGpPWpGaD
Lapatinib—ABCB1—Transmembrane transport of small molecules—AVP—hypothyroidism	4.46e-05	0.000406	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—PIK3C2A—hypothyroidism	4.19e-05	0.000381	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—TSHB—hypothyroidism	4.07e-05	0.00037	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—POMC—hypothyroidism	3.89e-05	0.000354	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—PRL—hypothyroidism	3.88e-05	0.000353	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—TSHB—hypothyroidism	3.63e-05	0.000331	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—PIK3C2A—hypothyroidism	3.63e-05	0.00033	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—VAV3—hypothyroidism	3.59e-05	0.000327	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	3.58e-05	0.000326	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—TSHB—hypothyroidism	3.54e-05	0.000323	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—SLC5A5—hypothyroidism	3.52e-05	0.00032	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—AVP—hypothyroidism	3.46e-05	0.000315	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—PIK3C2A—hypothyroidism	3.24e-05	0.000295	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	3.19e-05	0.000291	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—PIK3C2A—hypothyroidism	3.16e-05	0.000288	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—SLC5A5—hypothyroidism	3.05e-05	0.000277	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—SLC5A5—hypothyroidism	2.72e-05	0.000247	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—SLC5A5—hypothyroidism	2.65e-05	0.000241	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—POMC—hypothyroidism	2.3e-05	0.000209	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—IGF1—hypothyroidism	2.21e-05	0.000201	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—TSHB—hypothyroidism	2.18e-05	0.000199	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	1.95e-05	0.000177	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—POMC—hypothyroidism	1.84e-05	0.000167	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—SLC5A5—hypothyroidism	1.63e-05	0.000149	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—POMC—hypothyroidism	1.59e-05	0.000145	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—POMC—hypothyroidism	1.42e-05	0.000129	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—POMC—hypothyroidism	1.39e-05	0.000126	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—POMC—hypothyroidism	8.55e-06	7.78e-05	CbGpPWpGaD
